UY38550A - Compuestos inhibidores de inflamasoma nlrp3, composiciones, combinaciones y métodos relacionados - Google Patents

Compuestos inhibidores de inflamasoma nlrp3, composiciones, combinaciones y métodos relacionados

Info

Publication number
UY38550A
UY38550A UY0001038550A UY38550A UY38550A UY 38550 A UY38550 A UY 38550A UY 0001038550 A UY0001038550 A UY 0001038550A UY 38550 A UY38550 A UY 38550A UY 38550 A UY38550 A UY 38550A
Authority
UY
Uruguay
Prior art keywords
nlrp3
compositions
flamasoma
combinations
related methods
Prior art date
Application number
UY0001038550A
Other languages
English (en)
Spanish (es)
Inventor
Christopher Farady
Nina Gommermann
Philipp Janser
Angela Mackay
Henri Mattes
Nikolaus Johannes Stiefl
Juraj Velcicky
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2019/056278 external-priority patent/WO2020021447A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of UY38550A publication Critical patent/UY38550A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UY0001038550A 2019-05-17 2020-01-22 Compuestos inhibidores de inflamasoma nlrp3, composiciones, combinaciones y métodos relacionados UY38550A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19175246 2019-05-17
PCT/IB2019/056278 WO2020021447A1 (en) 2018-07-25 2019-07-23 Nlrp3 inflammasome inhibitors

Publications (1)

Publication Number Publication Date
UY38550A true UY38550A (es) 2020-12-31

Family

ID=66685350

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001038550A UY38550A (es) 2019-05-17 2020-01-22 Compuestos inhibidores de inflamasoma nlrp3, composiciones, combinaciones y métodos relacionados

Country Status (4)

Country Link
AR (1) AR117863A1 (zh)
EA (1) EA202190329A1 (zh)
TW (1) TW202110856A (zh)
UY (1) UY38550A (zh)

Also Published As

Publication number Publication date
EA202190329A1 (ru) 2021-05-18
AR117863A1 (es) 2021-09-01
TW202110856A (zh) 2021-03-16

Similar Documents

Publication Publication Date Title
ECSP21004787A (es) Inhibidores de inflamasoma nlrp3
CL2021003012A1 (es) Inhibidores del inflamasoma nlrp3
ECSP24014832A (es) Inhibidores de nlrp3
DOP2021000183A (es) Compuestos tricíclicos condensados útiles como agentes anticancerígenos
CO2019011762A2 (es) Compuestos que inhiben la proteína mcl-1
EA202091512A1 (ru) Производные сульфонилмочевины в качестве модуляторов nlrp3 инфламмасомы
CO2018000344A2 (es) Derivados de piperidina 1,4-sustituidos
BR112016028642A2 (pt) composto, composição farmacêutica, método de tratamento de uma doença ou condição, método de inibição da atividade de um polipeptídeo de fosfatidilinositol 3-quinase, método de inibição de reações imunes ou crescimento excessivo ou destrutivo ou de proliferação de células cancerosas, kit, e, uso de um composto, de um sal, de um isômero ou de uma mistura farmaceuticamente aceitável do mesmo.
CL2013002690A1 (es) Compuestos derivados de bis(fluoroalquil)-1,4-benzodiazepinona, inhibidores de notch; compuesto cristalino; composicion farmaceutica que los comprende; combinacion farmaceutica; y su uso para el tratamiento del cancer.
CL2022000201A1 (es) Inhibidores tricíclicos de kars dependientes de akr1c3
ECSP13013024A (es) 1,3-oxazinas como inhibidores de bace1 y/o bace2
ECSP13013068A (es) Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace2
UY31885A (es) Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones.
EA201990388A1 (ru) Пиперидиновые модуляторы рецепторов cxcr7
BR112016028814A2 (pt) ?composição farmacêutica, métodos de tratamento de uma doença ou condição, de inibição de reações imunitárias ou crescimento excessivo ou destrutivo ou de proliferação de células cancerosas, kit, composto, um sal, um isômero, ou uma mistura farmaceuticamente aceitável do mesmo, e, uso de um composto, de um sal, de um isômero, ou de uma mistura farmaceuticamente aceitável do mesmo?
UY38625A (es) Compuestos y su uso en el tratamiento del cáncer
UY33655A (es) Co-cristales y sales de inhibidores de ccr30
BR112021011325A2 (pt) Derivados de rapamicina
MX2020011405A (es) Derivados de bencimidazol como moduladores del receptor gamma huerfano (rory) relacionado con retinoide y usos farmaceuticos de los mismos.
CR20170513A (es) Derivados de pirazol útiles como inhibidores de proteína activadora de 5-li-poxigenasa (flap).
UY37729A (es) NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7
CR20180368A (es) Compuestos de dihidroquinolinsulfonamida de alquilo
CO2022012884A2 (es) Compuestos de amino pirimidina fusionados
CO2021001174A2 (es) Inhibidores de ckd8/19
BR112019024804A2 (pt) compostos bicíclicos 5,6-fundidos e composições para o tratamento de doenças parasíticas